Retrovirology (Sep 2012)

A dose-escalation clinical trial to evaluate the safety and immunogenicity of a replication-defective HIV-1 vaccine-HIVAX

  • Tung F,
  • Tung J,
  • Fischl M

DOI
https://doi.org/10.1186/1742-4690-9-S2-P127
Journal volume & issue
Vol. 9, no. Suppl 2
p. P127

Abstract

Read online

No abstracts available.